Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Alvar Agusti Garcia-Navarro (Barcelona, Spain). The future of personalised medicine in COPD. International Congress 2016 – Endotyping: the means to personalised medicine in lung disease

Member's Comments

No comment yet.

Related content which might interest you: A personalised medicine approach to ICS use in COPD Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care Year: 2019 Biomarkers and personalised medicine for asthma Source: Eur Respir J, 53 (1) 1802094; 10.1183/13993003.02094-2018 Year: 2019 In the era of personalized medicine, what are the current unmet needs in asthma? Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019 Predictive and personalised medicine for asthma using genomics Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine Year: 2012 What is evidence-based medicine? Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP) Year: 2006 Evaluation of the use of e-learning in training management of asthma and COPD in general medicine. Source: International Congress 2017 – Medical education, web and internet Year: 2017 What kind of emphasis do we need in clinical research to enable personalised respiratory medicine? Source: Eur Respir J, 55 (1) 1901866; 10.1183/13993003.01866-2019 Year: 2020 The impact of personalised therapies on respiratory medicine Source: Eur Respir Rev 2013; 22: 72-74 Year: 2013 The clinical benefit of personalised medicine in lung cancer Source: International Congress 2014 – Understanding the benefit of current personalised medicine platforms Year: 2014 Personalised medicine in asthma: from curative to preventive medicine Source: Eur Respir Rev 2017; 26: 160010 Year: 2017 Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021 Challenges in COPD exacerbations and future research and unknowns Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention Year: 2013 The contribution of evidence-based medicine Source: Annual Congress 2004 - PG17 - How to conduct a scientific survey on respiratory health Year: 2004 The impact of hands-on respiratory management for physicians in clinical practice and its future perspective Source: Annual Congress 2012 - Improving education for the healthcare team and patients Year: 2012 Personalised medicine in exacerbations of COPD: the beginnings Source: Eur Respir J 2012; 40: 1318-1319 Year: 2012 COPD – future prospects for women Source: Eur Respir J 2006; 28: Suppl. 50, 447s Year: 2006